Pulmonx Director French Glendon E. III Sells $161,800 in Company Stock
Express News | Pulmonx Corp - 5-Year Data Show Durable Benefits of Zephyr Valves
Express News | Pulmonx Announces Presentation of Clinical Data From the Aeriseal® Convert Trial and 5-Year Follow-up Data From the Liberate Study at the European Respiratory Society Congress 2024
Pulmonx Announces Presentation of Clinical Data From the AeriSeal CONVERT Trial and 5-Year Follow-up Data From the LIBERATE Study at the European Respiratory Society Congress 2024
Wells Fargo Reaffirms Their Hold Rating on Pulmonx (LUNG)
Wells Fargo Maintains Pulmonx(LUNG.US) With Hold Rating, Maintains Target Price $10
Wells Fargo analyst Larry Biegelsen maintains $Pulmonx(LUNG.US)$ with a hold rating, and maintains the target price at $10.According to TipRanks data, the analyst has a success rate of 64.6% and a